Telix to Participate in UBS Global Biopharma Conference

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Telix-Pharmaceuticals

More Like This

PR Newswire associated0

Telix to Present at Jefferies London Healthcare Conference 2023

PR Newswire associated0

Telix Announces Reorganisation to Deliver on Strategic Priorities

PR Newswire associated0

Telix Featured in 13 Abstracts at the Annual Congress of the European Association of Nuclear Medicine (EANM)

PR Newswire associated0

Telix Highlights Pivotal Trials in Prostate, Brain and Renal Cancers and Next Generation Theranostics at EANM

PR Newswire associated0

Telix 2024 Full Year Results: Record Financial Performance and Investment in Future Growth, FY2025 Guidance of up to $1.23 Billion

PR Newswire associated0

Telix Expands U.S. Development and Manufacturing Infrastructure with Acquisition of IsoTherapeutics

PR Newswire associated0

Telix 2023 Full Year Results: Inaugural Profit Achieved, Strong Revenue Growth Underpins Investment in Late-stage Pipeline

PR Newswire associated0

Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform